Regional quantification of D1, D2, and D3 dopamine receptor mRNA in rat brain using a ribonuclease protection assay
References (41)
- et al.
Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: a quantitative in situ hybridization study
Neuroscience
(1991) - et al.
Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA
Brain Res.
(1991) - et al.
Neuronal localization and modulation of the D2 dopamine receptor mRNA in brain of normal mice and mice lesioned with 6-hydroxydopamine
Neuropharmacology
(1991) - et al.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Anal. Biochem.
(1987) - et al.
Correlated asymmetries in striatal D1 and D2 binding: relationship to apomorphine-induced rotation
Brain Res.
(1988) - et al.
A molecular titration assay to measure transcript prevalence levels
Methods Enzymol.
(1987) - et al.
Dopamine D2-receptor mRNA level in rat striatum after chronic haloperidol treatment
Neurosci. Res.
(1991) - et al.
Developmental regulation of 5-HT2 and 5-HT1c mRNA and receptor levels
Dev. Brain Res.
(1991) - et al.
Tyrosine hydroxylase activity: regional and subcellular distribution in the brain
Brain Res.
(1974) - et al.
Molecular neurobiology of dopaminergic receptors
Int. Rev. Neurobiol.
(1993)
Distribution of dopamine D2 receptor mRNA splice variants in the rat by solution hybridization/protection assay
Neurosci. Lett.
The third dopamine receptor (D3) as a novel target for antipsychotics
Biochem. Pharmacol.
Stimulation of D2-dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of gamma-aminobutyric acid, glutamate or serotonin
Eur. J. Pharmacol.
New insights into dopamine receptors in the central nervous system
Neurochem. Int.
Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA level
Neurosci. Lett.
RNase ONE Advantages for nuclease protection assays
Promega Notes
Cloning and expression of a rat D2 dopamine receptor cDNA [see comments]
Nature
Molecular diversity of the dopamine receptors
Annu. Rev. Pharmacol. Toxicol.
p1B15: a cDNA clone of the rat mRNA encoding cyclophilin
DNA
Molecular cloning and expression of the gene for a human D1 dopamine receptor
Nature
Cited by (63)
Dopamine agonists in Parkinson's disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment
2023, Clinical Parkinsonism and Related DisordersNeurotransmitter Transporters and Their Role in the Pharmacological Actions of Therapeutic and Abused Drugs
2022, Comprehensive PharmacologyAntagonism of the D1- and D2-like dopamine receptors in the nucleus accumbens attenuates forced swim stress- and morphine priming-induced reinstatement of extinguished rats
2018, Behavioural Brain ResearchCitation Excerpt :The dopaminergic VTA projections that terminate in the core area of NAc play a crucial role in reward-related phenomena as well drug-seeking behaviors [2]. Previous studies have shown extensive presence of D1- and D2-like dopamine receptors in the NAc [3–6]. Morphine stimulates dopamine transmission in the NAc and causes changes in the mesocorticolimbic brain regions, which plays a critical role in regulating drug-seeking behaviors [7–11].
Role of D2 dopamine receptors of the ventral pallidum in inhibitory avoidance learning
2017, Behavioural Brain ResearchCitation Excerpt :Furthermore, it has been shown that the cocaine remarkably increases the DA level in the VP [9]. The DA receptors can be grouped in two major families (i.e. the D1- and the D2-subtype) [10–12], and in the VP, applying autoradiography [13,14] and mRNA immunhistochemistry [15,16] both DA receptor subtypes have been detected. It has been shown that the majority of VP neurons respond to systemic or local application of DA or its agonists [17–22].
- 1
Present adress: Cincinnati Veterans Affairs Medical Center, Department of Psychiatry, V-116A, 3200 Vine Street, Cincinnati, OH 45220, USA and Department of Psychiatry, University of Cincinnati College of Medicine, 231 Bethesda Avenue (ML 559), Cincinnati, OH 45267-0559, USA.